S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
Log in

Metlife Stock Price, Forecast & Analysis (NYSE:MET)

$49.27
-0.03 (-0.06 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$49.18
Now: $49.27
$49.73
50-Day Range
$44.30
MA: $46.71
$49.52
52-Week Range
$37.76
Now: $49.27
$51.16
Volume2.75 million shs
Average Volume4.76 million shs
Market Capitalization$45.31 billion
P/E Ratio9.14
Dividend Yield3.55%
Beta1.12
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. Read More…

Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.94 billion
Cash Flow$5.11 per share
Book Value$74.62 per share

Profitability

Net Income$5.12 billion

Miscellaneous

Employees48,000
Market Cap$45.31 billion
Next Earnings Date2/5/2020 (Estimated)
OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.


Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Tuesday, October 22nd. Shareholders of record on Tuesday, November 5th will be paid a dividend of $0.44 per share on Friday, December 13th. This represents a $1.76 annualized dividend and a yield of 3.57%. The ex-dividend date of this dividend is Monday, November 4th. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife declared that its board has initiated a share repurchase plan on Thursday, November 1st 2018, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 4.6% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's management believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) announced its quarterly earnings data on Wednesday, October, 30th. The financial services provider reported $1.27 earnings per share for the quarter, missing the consensus estimate of $1.40 by $0.13. The financial services provider had revenue of $16.92 billion for the quarter, compared to the consensus estimate of $16.37 billion. Metlife had a net margin of 10.82% and a return on equity of 8.82%. The business's quarterly revenue was up 3.2% on a year-over-year basis. During the same period last year, the firm posted $1.38 earnings per share. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Metlife.

What price target have analysts set for MET?

11 equities research analysts have issued twelve-month target prices for Metlife's stock. Their forecasts range from $41.00 to $57.00. On average, they anticipate Metlife's share price to reach $49.34 in the next year. This suggests a possible upside of 0.1% from the stock's current price. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife’s third-quarter 2019 operating earnings of $1.27 per share missed the Zacks Consensus Estimate by 9.93% and declined 8% year over year. Earnings suffered from increase in expenses, which offset revenue growth. The company’s shares have outperformed its industry, year to date. It has been performing well led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. Its disciplined capital deployment is expected to drive long-term growth and create wealth for shareholders. However, its exposure to catastrophe loss remains a concern. Investment in efficiency programs will likely put pressure on margins. Also, the company's net investment income might continue to decline in 2019 due to lower interest rates, which will likely pressurize investment yields." (11/6/2019)
  • 2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)

Has Metlife been receiving favorable news coverage?

Media stories about MET stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Metlife earned a daily sentiment score of -1.4 on InfoTrie's scale. They also assigned headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Metlife.

Are investors shorting Metlife?

Metlife saw a decrease in short interest in the month of October. As of October 31st, there was short interest totalling 8,500,000 shares, a decrease of 29.7% from the September 30th total of 12,090,000 shares. Based on an average daily trading volume, of 6,050,000 shares, the short-interest ratio is presently 1.4 days. Approximately 1.1% of the shares of the company are short sold. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include General Electric (GE), AT&T (T), Bank of America (BAC), IBM (IBM), Intel (INTC), Pfizer (PFE), Verizon Communications (VZ), Exxon Mobil (XOM), Gilead Sciences (GILD) and Cisco Systems (CSCO).

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
  • Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

Who are Metlife's major shareholders?

Metlife's stock is owned by many different of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (1.10%), Diamond Hill Capital Management Inc. (1.07%), Sumitomo Mitsui Trust Holdings Inc. (0.36%), California Public Employees Retirement System (0.21%), Robeco Institutional Asset Management B.V. (0.18%) and SPF Beheer BV (0.18%). Company insiders that own Metlife stock include Carlos M Gutierrez, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife.

Which major investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Alberta Investment Management Corp, State of New Jersey Common Pension Fund D, Douglas Lane & Associates LLC, Payden & Rygel, OLD Republic International Corp, New York State Teachers Retirement System and Rhumbline Advisers. Company insiders that have sold Metlife company stock in the last year include John D Mccallion and Steven J Goulart. View Insider Buying and Selling for Metlife.

Which major investors are buying Metlife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including Adams Diversified Equity Fund Inc., PGGM Investments, Railway Pension Investments Ltd, Commerzbank Aktiengesellschaft FI, Tibra Equities Europe Ltd, California Public Employees Retirement System, Bartlett & Co. LLC and Robeco Institutional Asset Management B.V.. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez and Gerald L Hassell. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $49.27.

How big of a company is Metlife?

Metlife has a market capitalization of $45.31 billion and generates $67.94 billion in revenue each year. The financial services provider earns $5.12 billion in net income (profit) each year or $5.39 on an earnings per share basis. Metlife employs 48,000 workers across the globe.View Additional Information About Metlife.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com/.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.


MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  802 (Vote Outperform)
Underperform Votes:  540 (Vote Underperform)
Total Votes:  1,342
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel